Ozan Pamir, CFA

Chief Financial Officer at Niagen Bioscience

Speaker

Ozan Pamir serves as Chief Financial Officer of Niagen Bioscience, where he leads the company's financial strategy, reporting, investor relations, business development and pharmaceutical strategy.

Prior to joining Niagen Bioscience, Mr. Pamir served as Chief Financial Officer of 180 Life Sciences, a NASDAQ-traded biotechnology company focused on inflammatory disease treatments, where he successfully managed the company's go-public and multiple funding rounds. His biotech experience extends to CFO and board member roles at two additional early-stage biotech companies.

Previously, Mr. Pamir was Vice President of Investment Banking at a leading independent investment bank, where he co-founded the Origination department and specialized in advising small and mid-cap life sciences companies on corporate strategy, financing, and M&A activities.

Mr. Pamir holds an Economics and Finance degree from McGill University and is a CFA Charterholder.